Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Portable MRI vendor Hyperfine launches public stock offering, misses $3.5M revenue target

The Guilford, Connecticut-based manufacturer saw quarterly revenues climb 27% compared to the second quarter of 2025, with scanners priced at $360,000 (up 36%). 

healthcare value value-based care money dollar

Cardiologist compensation hits an all-time high

Cardiologists, cardiac surgeons and cardiology APPs all earned more in 2024 than 2023, according to a new survey. Compensation in private practices continues to be much lower than it is integrated practices. 

Thumbnail

Medtech companies working together on robotic PFA system

Stereotaxis and CardioFocus are collaborating on a new robotic pulsed field ablation system. After completing some initial research, the companies are now working toward the launch of a clinical trial. 

Radiologists fear new $100,000 visa fee could exacerbate specialty’s staffing shortages

The Trump administration first announced this change via a presidential proclamation, with the added charge taking effect on Sept. 21. 

Thumbnail

Radiology platform startup OneImaging raises $38M in Series A financing

Founded in 2022, the company seeks to simplify radiology appointments for patients and providers, connecting them with a nationwide network of accredited centers. 

St. Louis Arch Missouri

Private equity-backed Solis Mammography enters new state with imaging center acquisition

The company now operates over 150 outpatient imaging centers across 23 major markets also including Dallas, Houston, Denver, D.C. and more. 

Medicare money payment

Medicare contractors mull restricting coverage for key image-guided pain procedure

Five of the seven MACs recently released proposed local coverage determinations, pertaining to peripheral nerve blocks. 

TrumpRx.gov Screenshot

TrumpRx now online as AstraZeneca becomes second pharmaceutical company to join

Details are still unclear. However, the administration—along with Pfizer and AstraZeneca, the two companies to sign on—promises the storefront will offer deeply discounted drugs directly to Americans. The deal allows the manufacturers to avoid import tariffs.